Patents by Inventor Hasse Kromann

Hasse Kromann has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7642367
    Abstract: The invention provides novel diamino-functionalized chalcone derivatives and analogues thereof. Use of the compounds, or compositions comprising them, as pharmaceutically active agents, in particular against bacterial and parasitic infections, is also disclosed. The invention further relates to a method for detecting inhibitory effects against e.g., bacteria, parasites, fungi, and helminths. The chalcones of the invention carry amino substituents and exhibit enhanced biological effects combined with improved metabolic and physicochemical properties, making the compounds useful as drug substances, in particular as antiparasitic and bacteriostatic agents.
    Type: Grant
    Filed: May 19, 2003
    Date of Patent: January 5, 2010
    Assignee: Lica Pharmaceuticals A/S
    Inventors: Simon Feldbæk Nielsen, Kristian Schønning, Hasse Kromann, Thomas Boesen, Mogens Larsen
  • Publication number: 20090186918
    Abstract: There is provided compounds of formula (I) wherein W is an optionally substituted aryl or heteroaryl group, and pharmaceutically-acceptable salts thereof, which compounds are useful in the treatment of diseases in which inhibition of the activity of a lipoxygenase (e.g. 15-lipoxygenase) is desired and/or required, and particularly in the treatment of inflammation.
    Type: Application
    Filed: October 27, 2006
    Publication date: July 23, 2009
    Inventors: Benjamin Pelcman, Andrei Sanin, Peter Nilsson, Hasse Kromann
  • Publication number: 20090143440
    Abstract: There is provided compounds of formula (I), wherein R1, R2, X1, X2 and n have meanings given in the description, and pharmaceutically-acceptable salts thereof, which compounds are useful in the treatment of diseases in which inhibition of the activity of a lipoxygenase (e.g. 15-lipoxygenase) is desired and/or required, and particularly in the treatment of inflammation.
    Type: Application
    Filed: October 27, 2006
    Publication date: June 4, 2009
    Applicant: BIOLIPOX AB
    Inventors: Benjamin Pelcman, Andrei Sanin, Peter Nilsson, Thomas Groth, Hasse Kromann
  • Publication number: 20090143455
    Abstract: There is provided compounds of formula I, wherein R1, R2, X1, X2 and n have meanings given in the description, and pharmaceutically-acceptable salts thereof, which compounds are useful in the treatment of diseases in which inhibition of the activity of a lipoxygenase (e.g. 15-lipoxygenase) is desired and/or required, and particularly in the treatment of inflammation.
    Type: Application
    Filed: October 19, 2006
    Publication date: June 4, 2009
    Inventors: Benjamin Pelcman, Andrei Sanin, Peter Nilsson, Thomas Boesen, Stine Byskov Vogensen, Hasse Kromann, Thomas Groth
  • Patent number: 7423181
    Abstract: The invention provides novel alkoxyaminochalcone derivatives and analogues thereof. Use of the compounds, or compositions comprising them, as pharmaceutically active agents, in particular against bacterial and parasitic infections, is also disclosed. The invention further relates to a method for detecting inhibitory effects against e.g., bacteria, parasites, fungi, and helminths. The chalcones of the invention carry amino substituents and exhibit enhanced biological effects combined with improved metabolic and physicochemical properties, making the compounds useful as drug substances, in particular as antiparasitic, bacteriostatic, and bacteriocidal agents.
    Type: Grant
    Filed: May 19, 2003
    Date of Patent: September 9, 2008
    Assignee: Lica Pharmaceuticals A/S
    Inventors: Simon Feldbæk Nielsen, Thomas Boesen, Mogens Larsen, Mette Bjerg Nielsen, Hasse Kromann
  • Publication number: 20060235073
    Abstract: The invention provides novel diamino-functionalised chalcone derivatives and analogues thereof. Use of the compounds, or compositions comprising them, as pharmaceutically active agents, in particular against bacterial and parasitic infections, is also disclosed. The invention further relates to a method for detecting inhibitory effects against e.g., bacteria, parasites, fungi, and helminths. The chalcones of the invention carry amino substituents and exhibit enhanced biological effects combined with improved metabolic and physicochemical properties, making the compounds useful as drug substances, in particular as antiparasitic and bacteriostatic agents.
    Type: Application
    Filed: May 19, 2003
    Publication date: October 19, 2006
    Inventors: Simon Nielsen, Kristian Schønning, Hasse Kromann, Thomas Boesen, Mogens Larsen
  • Publication number: 20060052600
    Abstract: The invention provides novel amino-functionalised chalcone derivatives and analogues thereof. Use of the compounds, or compositions comprising them, as pharmaceutically active agents, in particular against bacterial and parasitic infections, is also disclosed. The invention further relates to a method for detecting inhibitory effects against e.g., bacteria, parasites, fungi, and helminths. The chalcones of the invention carry amino substituents and exhibit enhanced biological effects combined with improved metabolic and physicochemical properties, making the compounds useful as drug substances, in particular as antiparasitic, and bacteriocidal agents.
    Type: Application
    Filed: May 19, 2003
    Publication date: March 9, 2006
    Inventors: Simone Nielsen, Hasse Kromann, Mogens Larsen, Majbritt Hansen, Thomas Boesen
  • Publication number: 20050227990
    Abstract: The invention provides novel alkoxyaminochalcone derivatives and analogues thereof. Use of the compounds, or compositions comprising them, as pharmaceutically active agents, in particular against bacterial and parasitic infections, is also disclosed. The invention further relates to a method for detecting inhibitory effects against e.g., bacteria, parasites, fungi, and helminths. The chalcones of the invention carry amino substituents and exhibit enhanced biological effects combined with improved metabolic and physicochemical properties, making the compounds useful as drug substances, in particular as antiparasitic, bacteriostatic, and bacteriocidal agents.
    Type: Application
    Filed: May 19, 2003
    Publication date: October 13, 2005
    Applicant: Lica Pharmaceuticals A/S
    Inventors: Simon Nielsen, Thomas Boesen, Mogens Larsen, Mette Bjerg Nielsen, Hasse Kromann